logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Do‐Youn Oh

Seoul National University Hospital

81H-index
949Paper Count
4.3WCitation Count
Published Papers 260
Publication Date
logo
From screening to surveillance: integrated prevention of <em>Helicobacter pylori</em>–associated gastric cancer in the Asia-Pacific region
errLancet Regional Health-Western Pacific
IF8.1
err2026-08-17
err0
errOAAI
errJeesun Yoon; Do-Youn Oh
errShare
errSave
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial
errEClinicalMedicine
IF10
err2026-08-07
err0
errOAAI
errDiego Ferone; Marianne Pavel; Ken Herrmann; Pamela L. Kunz; Sten Myrehaug; Daniel Halperin; Beth Chasen; Jaume Capdevila; Amparo García-Burillo; Salvatore Tafuto; Secondo Lastoria; Do-Youn Oh; Changhoon Yoo; Stephen Falk; Thorvardur R. Halfdanarson; Maddalena Sansovini; Laura Gerard; Emmanuel Deshayes; Angelina Filice; Ilya Folitar
errShare
errSave
Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing biliary tract or pancreatic tumors: a subgroup analysis of DESTINY-PanTumor02
errESMO Open
IF8.3
err2026-07-30
err0
errOAAI
errD.-Y. Oh; I. Ługowska; D. Stroyakovskiy; K.H. Jung; O. Dumas; K. Penkov; A. Dechaphunkul; A. Oaknin; S.T. Kim; N. Starling; B. Chewaskulyong; C. Charonpongsuntorn; D. Doroshow; S.-Y. Hsiao; Y.-P. Hung; L. Jung; N. Kuptsova-Clarkson; F. Michelini; S. Puvvada; F. Meric-Bernstam
errShare
errSave
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study
errJournal of Hepatology
IF33
err2026-07-06
err0
errOAAI
errDo-Youn Oh; Masafumi Ikeda; Teresa Macarulla; Aiwu Ruth He; Joon Oh Park; Masayuki Kitano; Guido Giordano; Kyu-pyo Kim; Thomas Wirth; David Tai; Mohamed Bouattour; Tiziana Pressiani; Farshid Dayyani; Angela Lamarca; Ugochinyere Emeribe; Susanne Radke; Peng Sun; Boris Baur; Arndt Vogel
errShare
errSave
Open-label, single-arm, phase 2 trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancer
errJournal of Hepatology
IF33
err2025-11-24
err0
errOAAI
errJeesun Yoon; Choong-kun Lee; Jin Won Kim; Beodeul Kang; Se Jun Park; Ji-Won Kim; Hong Jae Chon; Hye Jin Choi; Myung Ah Lee; Tae-Yong Kim; Do-Youn Oh
errShare
errSave
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up
errAdvances in Therapy
IF4
err2025-11-18
err0
errOAAI
errMarcia Cruz-Correa; Do-Youn Oh; Ken Kato; Josep Tabernero; Yuxian Bai; Jianhua Shi; Keun-Wook Lee; Hidekazu Hirano; David Spigel; Lucjan Wyrwicz; Roberto Pazo Cid; Antonio Cubillo Gracián; Yaling Xu; Tao Sheng; Silu Yang; Rui-Hua Xu; Markus Moehler
errShare
errSave
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
errNature Medicine
IF50
err2025-10-18
err0
errOAAI
errYelena Y. Janjigian; Do-Youn Oh; Meredith Pelster; Zev A. Wainberg; Subhransu Prusty; Sandahl Nelson; Amy DuPage; Amy Thompson; Daniel O. Koralek; Edward Allan R. Sison; Sun Young Rha
errShare
errSave
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
errEuropean Journal of Cancer
IF7.1
err2025-09-20
err0
PREAI
errMaeve A. Lowery; Lucjan S. Wyrwicz; Do-Youn Oh; Kai-Keen Shiu; Patricio Yañez; Yuxian Bai; Min-Hee Ryu; Jeeyun Lee; Fernando Rivera; Gustavo Vasconcelos Alves; Marcelo Garrido; Manuel González Fernández; Jin Li; Timuçin Çil; Felipe Melo Cruz; Shukui Qin; Yanfen Guan; Adriana Valderrama; Sonal Bordia; Sun Young Rha
errShare
errSave
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer
errONCOLOGIST
IF4.2
err2025-07-01
err0
errOAAI
errAntonuzzo, Lorenzo; Takahashi, Hidenori; Park, Joon Oh; Sookprasert, Aumkhae; Gillmore, Roopinder; Yang, Sheng-Shun; Cundom, Juan; Petrova, Mila; Vaccaro, Gina; Holmblad, Marielle; Zotkiewicz, Magdalena; Wang, Julie; Rokutanda, Nana; Oh, Do-Youn
errShare
errSave
YAP as a therapeutic target to reverse trastuzumab resistance
errGastric Cancer
IF5.1
err2025-06-20
err0
errOAAI
errAh-Rong Nam; Kyoung-Seok Oh; Ju-Hee Bang; Yoojin Jeong; Sea Young Choo; Hyo Jung Kim; Su In Lee; Jae-Min Kim; Jeesun Yoon; Tae-Yong Kim; Do-Youn Oh
errShare
errSave
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
errlancet oncology
IF0
err2025-06-02
err0
PREAI
errElena Elimova; Jaffer Ajani; Howard Burris; Crystal S Denlinger; Syma Iqbal; Yoon-Koo Kang; Jwa Hoon Kim; Keun-Wook Lee; Bruce Lin; Rutika Mehta; Do-Youn Oh; Sun Young Rha; Young Mi Seol; Lin Yang; Mark A Ozog; Phillip M Garfin; Geoffrey Ku
errShare
errSave
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
errJournal of Hepatology
IF33
err2025-05-15
err0
errOAAI
errDo-Youn Oh; Aiwu Ruth He; Shukui Qin; Li-Tzong Chen; Takuji Okusaka; Jin Won Kim; Thatthan Suksombooncharoen; Myung Ah Lee; Masayuki Kitano; Howard A. Burris; Mohamed Bouattour; Suebpong Tanasanvimon; Renata Zaucha; Antonio Avallone; Juan Cundom; Aleksandra Kuzko; Julie Wang; Ioannis Xynos; Arndt Vogel; Juan W. Valle
errShare
errSave
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errMoehler, Markus; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Lee, Keun-Wook; Rha, Sun Young; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Wyrwicz, Lucjan; Disel, Umut; Pazo-Cid, Roberto A.; Fornaro, Lorenzo; Xu, Yaling; Sheng, Tao; Yang, Silu; Kadva, Alysha; Cruz-Correa, Marcia; Xu, Rui-Hua
errShare
errSave
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial
errNATURE CANCER
IF28.5
err2025-02-20
err0
PREAI
errMarabelle, Aurelien; O'Malley, David M.; Hendifar, Andrew E.; Ascierto, Paolo A.; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni; De Jesus-Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Yao, Lili; Jin, Fan; Gozman, Alexander; Maio, Michele
errShare
errSave
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer (vol 9, 103647, 2024)
errESMO OPEN
IF8.3
err2025-01-01
err0
errOAAI
errChen, L. -T.; Vogel, A.; Hsu, C.; Chen, M. -H.; Fang, W.; Pangarsa, E. A.; Sharma, A.; Ikeda, M.; Park, J. O.; Tan, C. K.; Regala, E.; Tai, D.; Tanasanvimon, S.; Charoentum, C.; Chee, C. E.; Lui, A.; Sow, J.; Oh, D. -Y.; Ueno, M.; Ramaswamy, A.; Jeo, W. S.; Zhou, J.; Curigliano, G.; Yoshino, T.; Bai, L. -Y.; Pentheroudakis, G.; Chiang, N. -J.; Cervantes, A.; Chen, J. -S.; Ducreux, M.
errShare
errSave
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma from the Randomized Phase Ib/II MORPHEUS Trial
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2024-12-20
err0
errOAAI
errKo, Andrew H.; Oh, Do-Youn; Lau, Janet; Mhatre, Shivani K.; Ci, Bo; Machado, Robson; Li, Shi; Bretscher, Michael T.; Reyes-Rivera, Irmarie; Zhu, Jiawen; Zhang, Xiaosong; Patel, Jilpa; Psioda, Matthew A.; Ponz-Sarvise, Mariano
errShare
errSave
Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
errESMO OPEN
IF8.3
err2024-12-01
err1
PREAI
errKim, T. Y.; Kwak, Y.; Nam, S. K.; Han, D.; Oh, D. Y.; Im, S. A.; Lee, H. S.
errShare
errSave
Delayed Separation of Kaplan-Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis
errTARGETED ONCOLOGY
IF4
err2024-11-10
err0
errOAAI
errOh, Do-Youn; Rokutanda, Nana; Zotkiewicz, Magdalena; He, Philip; Stocks, Jennifer; Johnson, Melissa L.
errShare
errSave
Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer
errFUTURE ONCOLOGY
IF2.6
err2024-10-28
err0
errOAAI
errMeric-Bernstam, Funda; Hollebecque, Antoine; Furuse, Junji; Oh, Do-Youn; Bridgewater, John A.; Anderson, Bailey; Hangai, Nanae; Wacheck, Volker; Goyal, Lipika
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
J
Jerrold M. Olefsky
H-index: 147 · Papers: 672
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
P
Paolo A. Ascierto
H-index: 126 · Papers: 1.7K
H
Howard A. Burris
H-index: 117 · Papers: 1.1K
View more